Advertisement

Boston Scientific and Glengary lead as investors in a $3.5 million funding round for chronic pain management devices maker Neuros Medical.

Neuros Medical logo

Cleveland, OH- based Neuros Medical announced that it raised $3.5 million in its latest round of funding, with Boston Scientific (NYSE:BSX) and Glengary leading the investment.

Neuros recently received an investigational device exemption from the FDA to evaluate its chronic pain management system, the electrical nerve block, for use in amputee patients to manage pain in the residual limb.

Advertisement
Advertisement